Affiliation:
1. Lymphoma Research Foundation
Abstract
In this month’s CME article, Vercellino and colleagues report results of a secondary analysis of diffuse large B-cell lymphoma patients in the REMARC trial who had baseline positron emission tomography scans, thereby demonstrating that metabolic tumor volume combined with performance status allowed risk stratification of patients before treatment and predicted survival independent of response to chemoimmunotherapy.
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献